Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Bay Pines VA Healthcare System
839
mi
from 43215
Bay Pines, FL
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Bay Pines VA Healthcare System
839
mi
from 43215
Bay Pines, FL
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Comprehensive Wound Healing Center
830
mi
from 43215
Clearwater, FL
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Comprehensive Wound Healing Center
830
mi
from 43215
Clearwater, FL
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Osceola Regional Wound Care Center
811
mi
from 43215
Kissimmee, FL
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Osceola Regional Wound Care Center
811
mi
from 43215
Kissimmee, FL
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Doctors Research Network
997
mi
from 43215
South Miami, FL
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Doctors Research Network
997
mi
from 43215
South Miami, FL
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Robert Snyder, DPM, CWS
963
mi
from 43215
Tamarac, FL
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Robert Snyder, DPM, CWS
963
mi
from 43215
Tamarac, FL
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Aiyan Diabetes Center
447
mi
from 43215
Evans, GA
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Aiyan Diabetes Center
447
mi
from 43215
Evans, GA
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Broadlawns Medical Center
566
mi
from 43215
Des Moines, IA
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Broadlawns Medical Center
566
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Boston Medical Center, Department of Vascular Surgery
643
mi
from 43215
Boston, MA
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Boston Medical Center, Department of Vascular Surgery
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Covenant Wound Healing Center
244
mi
from 43215
Saginaw, MI
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Covenant Wound Healing Center
244
mi
from 43215
Saginaw, MI
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Advanced Foot and Ankle Center
1758
mi
from 43215
Las Vegas, NV
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Advanced Foot and Ankle Center
1758
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Overlook Hospital Wound Healing Program
458
mi
from 43215
Summit, NJ
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Overlook Hospital Wound Healing Program
458
mi
from 43215
Summit, NJ
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
University of North Carolina Division of Vascular Surgery
354
mi
from 43215
Chapel Hill, NC
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
University of North Carolina Division of Vascular Surgery
354
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Health Center
213
mi
from 43215
Erie, PA
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Health Center
213
mi
from 43215
Erie, PA
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
615
mi
from 43215
Warwick, RI
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
615
mi
from 43215
Warwick, RI
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Jackson Madison County General Hospital
431
mi
from 43215
Jackson, TN
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Jackson Madison County General Hospital
431
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Private Practice FA fur Dermatologie Clinical Centre
mi
from 43215
Hartberg,
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Private Practice FA fur Dermatologie Clinical Centre
mi
from 43215
Hartberg,
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Southern Arizona VA Health Care System (SAVAHCS)
1642
mi
from 43215
Tucson, AZ
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Southern Arizona VA Health Care System (SAVAHCS)
1642
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
University of Arizona College of Medicine
1639
mi
from 43215
Tucson, AZ
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
University of Arizona College of Medicine
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Foot & Ankle Associates of Florida
mi
from 43215
Altamonte Springs, FL
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Foot & Ankle Associates of Florida
mi
from 43215
Altamonte Springs, FL
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Heartland Regional Medical Center
624
mi
from 43215
Saint Joseph, MO
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Heartland Regional Medical Center
624
mi
from 43215
Saint Joseph, MO
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated:  12/31/1969
Dixie Regional Meidcal Center
mi
from 43215
Saint George, UT
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Dixie Regional Meidcal Center
mi
from 43215
Saint George, UT
Click here to add this to my saved trials
Utility of Interface Pressure Mapping
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Utility of Interface Pressure Mapping
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
Safety, Reactogenicity, Tolerability, Immunogenicity and Efficacy of Live Attenuated ETEC ACE527 Vaccine Administered Alone or With a Double Mutant E. Coli Heat Labile Toxin (dmLT) in Healthy Adult Volunteers
Status: Enrolling
Updated:  12/31/1969
Center for Immunization Research (CIR) at Johns Hopkins School of Public Health (JHSPH)
344
mi
from 43215
Baltimore, MD
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
Safety, Reactogenicity, Tolerability, Immunogenicity and Efficacy of Live Attenuated ETEC ACE527 Vaccine Administered Alone or With a Double Mutant E. Coli Heat Labile Toxin (dmLT) in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Center for Immunization Research (CIR) at Johns Hopkins School of Public Health (JHSPH)
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Rectovaginal Fistulizing Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Rectovaginal Fistulizing Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Status: Enrolling
Updated:  12/31/1969
University of Chicago
270
mi
from 43215
Chicago, IL
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Status: Enrolling
Updated: 12/31/1969
University of Chicago
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated:  12/31/1969
UCLA Jonsson Comprehensive Cancer Center
1982
mi
from 43215
Los Angeles, CA
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
UCLA Jonsson Comprehensive Cancer Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal
Status: Enrolling
Updated:  12/31/1969
UCLA Jonsson Comprehensive Cancer Center
1982
mi
from 43215
Los Angeles, CA
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal
Status: Enrolling
Updated: 12/31/1969
UCLA Jonsson Comprehensive Cancer Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Arkansas Gastroenterology
615
mi
from 43215
Sherwood, AR
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Arkansas Gastroenterology
615
mi
from 43215
Sherwood, AR
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Hope Clinical Research, LLC
1987
mi
from 43215
Canoga Park, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Hope Clinical Research, LLC
1987
mi
from 43215
Canoga Park, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
TriWest Research Associates, LLC
1939
mi
from 43215
El Cajon, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
TriWest Research Associates, LLC
1939
mi
from 43215
El Cajon, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Beverly Hills Center for Digestive Health
1978
mi
from 43215
Los Angeles, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Beverly Hills Center for Digestive Health
1978
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Precision Research Institute, LLC
1951
mi
from 43215
San Diego, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Precision Research Institute, LLC
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Medical Associates Research Group
1947
mi
from 43215
San Diego, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Medical Associates Research Group
1947
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Care Access Research
2098
mi
from 43215
San Pablo, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Care Access Research
2098
mi
from 43215
San Pablo, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
2100
mi
from 43215
Stanford, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Medical Research Center of Connecticut, LLC
539
mi
from 43215
Hamden, CT
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Medical Research Center of Connecticut, LLC
539
mi
from 43215
Hamden, CT
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Nature Coast Clinical Research
772
mi
from 43215
Inverness, FL
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Nature Coast Clinical Research
772
mi
from 43215
Inverness, FL
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Sunrise Medical Research
966
mi
from 43215
Lauderdale Lakes, FL
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Sunrise Medical Research
966
mi
from 43215
Lauderdale Lakes, FL
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Southwest Gastroenterology
275
mi
from 43215
Oak Lawn, IL
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Southwest Gastroenterology
275
mi
from 43215
Oak Lawn, IL
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Rockford Gastroenterology Associates, Ltd.
349
mi
from 43215
Rockford, IL
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Rockford Gastroenterology Associates, Ltd.
349
mi
from 43215
Rockford, IL
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Cotton-O'Neil Clinical Research Center, Digestive Health
676
mi
from 43215
Topeka, KA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center, Digestive Health
676
mi
from 43215
Topeka, KA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Metro Health
243
mi
from 43215
Wyoming, MI
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Metro Health
243
mi
from 43215
Wyoming, MI
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Research Institute of the Carolinas, PLC
324
mi
from 43215
Mooresville, NC
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Research Institute of the Carolinas, PLC
324
mi
from 43215
Mooresville, NC
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Carolina's GI Research LLC
370
mi
from 43215
Raleigh, NC
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Carolina's GI Research LLC
370
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Pmg Research Of Salisbury
328
mi
from 43215
Salisbury, NC
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Pmg Research Of Salisbury
328
mi
from 43215
Salisbury, NC
Click here to add this to my saved trials